Sunday, November 13, 2022 11:34:55 AM
Well they do employ specialists in the area of uplisting and stock behavior i thought?
Ok I’ll dive into the trap statement:
Defending a share price is not supposed to be something a company has to explicitly state in a pr. Although I dare say they have mentioned before having malicious characters set out to diminish share price (I think they even got a Washington post reporter on the case once upon a time) normally it would just be seen in actions of work such as applying for product approvals, ramping up manufacturing, rallying scientific community, etc. it’s quite possible to see may 10th as an attempt to start a process that would have been very very positive for shareholders but ultimately did get bungled.
If that is the case and there is a malicious 3rd party that caused this to happen on may 10th well we can at least rest easy knowing that nwbo has on staff experts that should be able to accurately predict where the share price would have and should have gone if all plans had proceeded unhindered and the difference in price between that plan and the new one they are having to adopt moving forward.
Again this is all conjecture by my part and per usual in 6months I’ll probably be proven wrong yet again with nothing actionable on this front having happened lol
Ok I’ll dive into the trap statement:
Defending a share price is not supposed to be something a company has to explicitly state in a pr. Although I dare say they have mentioned before having malicious characters set out to diminish share price (I think they even got a Washington post reporter on the case once upon a time) normally it would just be seen in actions of work such as applying for product approvals, ramping up manufacturing, rallying scientific community, etc. it’s quite possible to see may 10th as an attempt to start a process that would have been very very positive for shareholders but ultimately did get bungled.
If that is the case and there is a malicious 3rd party that caused this to happen on may 10th well we can at least rest easy knowing that nwbo has on staff experts that should be able to accurately predict where the share price would have and should have gone if all plans had proceeded unhindered and the difference in price between that plan and the new one they are having to adopt moving forward.
Again this is all conjecture by my part and per usual in 6months I’ll probably be proven wrong yet again with nothing actionable on this front having happened lol
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
